eg5 inhibitor v, trans24

Eg5 Inhibitor V, trans-24 是一种有效的、特异性的驱动蛋白 Eg5 抑制剂，IC50 值为 0.65 μM，可用于癌症的研究。

GSK-3 Inhibitor 5 (4-Cyanophenacyl bromide) 是一种酮类衍生物，可作为医药和有机合成的中间体，且对糖原合成酶激酶3(GSK-3)有抑制作用。

5-LOX inhibitor (1-(sec-Butyl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-1H-1,2,4-triazol-5(4H)-one) 是伊曲康唑杂质之一，是一种选择性 LOX-5 抑制剂。

1-[4-(2,3-dihydro-1,4-benzodioxine-6-sulfonyl)piperazin-1-yl]-2-(6-methyl-1-benzofuran-3-yl)ethan-1-one 是一种有机结构单元。

Tubulin inhibitor 24 是一种 tubulin 抑制剂，可以抑制微管蛋白聚合，以浓度依赖性方式诱导细胞周期停滞在 G2 M 期， 具有抗肿瘤活性且无明显毒性。

PKI (5-24) Acetate(99534-03-9 free base) 是一种高亲和力 PKA 抑制剂 (Ki = 2.3 nM)。

ATX inhibitor 5 是一种有效且具有口服活性的 autotaxin (ATX) 抑制剂（IC50 ： 15.3 nM），可降低 CCl4 诱导的肝纤维化水平，具有抗肝纤维化作用，。

ADAMTS-5 Inhibitor 是 ADAMTS-5 的抑制剂，IC50 为 1.1 µM，可用于关节炎中软骨破坏的研究。

Thrombin inhibitor 5 (compound 385) 是一种凝血酶抑制剂，IC50范围为 0.1 μM~1 μM，可用于静脉血栓栓塞的研究。

BRD4 Inhibitor-24 是一种具有抗肿瘤活性的 BRD4 小分子抑制剂。

Topoisomerase II inhibitor 5 (Compound E24) 是一种 DNAtopoisomerase II 抑制剂，具有抗癌作用。

PKI (5-24),amide (IP20-amide)为对应于cAMP依赖性蛋白激酶热稳定抑制蛋白活性部分的20残基肽。该化合物是一种高效的cAMP依赖性蛋白激酶(PKA)抑制剂，具有2.3 nM的Ki值。

3-Cyanovinyl-9-(5’-O-(4,4’-dimethoxytrityl)-2’-deoxyribofuranosyl)carbazole (trans: CAS#1044273-26-8) 是一种有用的有机化合物，可用于生命科学领域的相关研究，其产品编号为 TNU0955。

Chol-5-en-24-al-3β-ol is a steroid compound.

Topoisomerase I inhibitor 5 is an efficient inhibitor of topoisomerase I, with an IC50 value. It effectively disrupts DNA and inhibits the activity of topoisomerase I. Moreover, it can induce apoptosis in MCF-7 cells and arrest the cell cycle at the G1 phase. Topoisomerase I inhibitor 5 also exhibits potency in reversing P-gp-mediated resistance to Adriamycin [1].

trans-5-Hydroxyferulic acid 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 T126397，CAS号为 110642-42-7。

Tuberculosis inhibitor 5 (Compound 11i) 是一种有效的抗结核剂，无明显细胞毒性。Tuberculosis inhibitor 5 是一种抗分枝杆菌 (antimycobacterial) 联苯类似物。

IRAK inhibitor 4 is a compound that functions as an inhibitor of interleukin-1 receptor-associated kinase 4 (IRAK4). It specifically targets and inhibits the activity of IRAK4. The (trans) form of IRAK inhibitor 4 refers to its specific molecular configuration.

3α-Acetoxyurs-5:12-dien-24-oic acid 为从Boswellia sacra Fluckiger分离所得的一种天然化合物。

5(S),6(R)-11-trans DiHETE is a C-11 double bond isomer of 5(S),6(R)-DiHETE that is formed by the enzymatic isomerization of 5(S),6(R)-DiHETE by a membrane bound factor. 5(S),6(R)-11-trans DiHETE has been found in rat kidney homogenates and is potentially formed by the epoxide hydrolase pathway in this tissue. The isomerase activity responsible for the conversion of leukotriene B4 (LTB4) to 6-trans LTB4 in rat kidney homogenates has also been implicated in its formation. 5(S),6(R)-11-trans DiHETE is not a substrate for soybean lipoxygenase. The biological activity of 5(S),6(R)-11-trans DiHETE has not been reported.

5-trans-Prostaglandin E2 accelerates fibrinolysis by enhancing plasminogen activation mediated by tissue-type plasminogen activator. It also inhibits platelet aggregation in human PRP.

Calpain inhibitor V (Mu-Val-HPh-FMK) 为具抗衣原体活性的细胞渗透性不可逆钙蛋白酶抑制剂。

JAK2 Inhibitor V (JAK2 Inhibitor V Z3) 是一种新型的 Jak2 特异性抑制剂，以剂量依赖性方式抑制 Jak2-V617F 和 Jak2-WT 自磷酸化。

α-Synuclein inhibitor 5 是一种有效的、能够透过血脑屏障的 α-Synuclein (α-Syn) 聚集的抑制剂 (IC50: 1.22 μM)，在 30 μM 时的抑制率为 94.3%。

ChoKα inhibitor-5，一种含硫胆碱激酶(Choline Kinase)抑制剂，对HChoK α1表现出显著抑制效果，IC50值为0.64 μM。此外，该化合物还可诱导细胞凋亡，常用于癌症相关研究领域。

Cloprostenol is a synthetic derivative of prostaglandin F2α that is used in veterinary medicine as a luteolytic agent for the induction of estrus and in the treatment of reproductive disorders in cattle, swine, and horses. (+)-5-trans Cloprostenol is a minor impurity produced in the synthesis of (+)-cloprostenol. The (+)-5-trans isomer is 20-fold less active than the 5-cis form in terminating pregnancy in the hamster.

sEH inhibitor-5 是一种 sEH (可溶性环氧化物水解酶) 的有效抑制剂 (IC50: 0.1 nM)。

FAK inhibitor 5 is a novel allosteric FAK inhibitor, with IC50 values in the low micromolar range.

Microtubule inhibitor 5 (compound 17f) is a highly potent cytotoxic agent that inhibits microtubule function. It exhibits a substantial cytotoxic effect on NCI-H460 cells, with an IC50 value of 154.5 nM. Moreover, this compound demonstrates excellent cell permeability [1].

PI3Kγ inhibitor 5 is a potent inhibitor of phosphoinositide 3-kinase γ (PI3Kγ), exhibiting an exceptional IC50 value of 34 nM.

PKI PKA Inhibitor (5-24) is a synthetic peptide inhibitor of PKA (cAMP-dependent protein kinase) (Ki= 2.3 nM) derived from the active site of the skeletal muscle inhibitor protein.1It mimics the protein substrate by binding to the catalytic site through the arginine-cluster basic subsite.1The prominent enzyme-substrate interaction site occurs where PKA catalytic subunit residues Tyr235and Phe239form a sandwich-like structure with residue Phe10of PKI (5-24).2

5-trans-17-phenyl trinor Prostaglandin F2α (5-trans-17-phenyl trinor PGF2α) represents the 5-trans isomer and the free acid variant of 17-phenyl trinor PGF2α, distinct from its ethyl amide and dimethyl amide derivatives. This compound serves as a potential impurity in 17-phenyl trinor PGF2α formulations. It is utilized as an analytical standard for the detection and quantification of itself in 17-phenyl trinor PGF2α preparations.

'5-HT NA Reuptake inhibitor-1 (compound 9) 作为一种选择性的双重5-HT和NA再摄取抑制剂，其IC50值分别为660 nM和70 nM。该化合物在人体体外展现出优良的代谢稳定性、hERG 选择性以及被动膜通透性。'

PKI(5-24) TFA 是一种强效、竞争性、合成的PKA(cAMP 依赖性蛋白激酶) 抑制剂，Ki 为 2.3 nM。PKI(5-24) TFA 对应于天然存在的热稳定蛋白激酶抑制剂中的 5-24 残基。

c-Myc inhibitor5 (DA3) 是一种荧光长链桥双嘌呤，可选择性靶向 c-MYCG-四链体(KD16 μM)。c-Myc inhibitor5 显示对 c-MYC 表达的抑制作用，而不是其他 G4 驱动的癌基因。

HIF-1 inhibitor-5 (Compound 16e) 是一种有效的 HIF-1抑制剂，其 IC50为 2.38 μM。HIF-1 inhibitor-5 具有抗血管生成潜能。

V (human PD-L1 inhibitor) 是一种与human PD-1 protein结合的肽，具有3.32 μM的Kd值，能有效抑制PD-1 PD-L1之间的相互作用。

WIN site inhibitor 1 TFA is a WIN site of chromatin-associated WD repeat-containing protein 5 (WDR5) inhibitor (Kd: 0.1 nM).

Protein kinase inhibitor 5 sulfate hydrate 作为TRK-A抑制剂，具有高效性，其IC50值仅为1.8 nM，能有效抑制细胞活力。

WRN inhibitor 5（例157）为环状乙烯基砜化合物，充当韦默综合征ATP依赖性解旋酶（WRN）的抑制剂，适用于癌症研究领域。

Pim-1 kinase inhibitor 5 (Compound 4c)是一种选择性Pim-1激酶抑制剂，具有0.61 μM的半抑制浓度(IC50)。该化合物对HepG2、MCF-7、PC3和HCT-116癌细胞系表现出细胞毒性，其IC50s值介于6.95至20.19 μM之间。

IDH1 Inhibitor 5 (compound 2) 是一种 IDH1（异柠檬酸脱氢酶 1）的抑制剂。IDH1 Inhibitor 5 能够抑制 MOG 细胞 (IC50: 64.4 nM) 以及表达外源突变 IDH1 R132H 蛋白的野生型 IDH1 胶质瘤细胞 (IC50: 34.9 nM)。

ITK inhibitor 5 (compound 27) is a highly potent and selectively targeted inhibitor of ITK. It exhibits IC50 values of 5.6 nM and 25 nM for ITK and BTK respectively [1].

KRAS G12C inhibitor 5 is a KRas G12C inhibitor.

Compound 16d, 或称为 Monoamine OxidaseB inhibitor 5，是一种针对单胺氧化酶 B (hMAO-B) 的选择性可逆性抑制剂，具有IC50值为 67.3 nM 和 Ki值为 82.5 nM。在大鼠模型中，该化合物表现出优秀的药代动力学属性并具有低毒性。此外，Compound 16d 能有效改善帕金森病小鼠模型中由 MPTP 引起的运动障碍，且可穿透血脑屏障 (BBB)。

Cathepsin K inhibitor 5 functions as a powerful inhibitor of Cathepsin K [1].

5-transU-44069 是 血栓素 受体激动剂 U-44069 的反式 异构体，抑制 前列腺素 E2 合成酶 活性。

SIRT5 inhibitor5，作为一种高效SIRT5抑制剂，其IC50为0.21 µM，特点是不占据NAD+结合口袋，而是作为一种竞争性底物抑制剂。